| | 128-46-1 Basic information More.. |
| Product Name: | Dihydrostreptomycin | | Synonyms: | DIHYDROSTREPTOMYCIN;Dihydrostreptomycin (base and/or unspecified salts);2-[(1S,3R,4S,5R,6R)-5-(Diaminomethylideneamino)-2-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-methylaminooxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-3,4,6-trihydroxycyclohexyl]guanidine;Acetonitrile, 2-benzimidazolyl-;Benzimidazole, 2-cyanomethyl;4-O-[2-O-[2-(Methylamino)-2-deoxy-α-L-glucopyranosyl]-5-deoxy-3-hydroxymethyl-α-L-lyxofuranosyl]-N,N'-bis(aminoiminomethyl)-D-streptamine;DHSM;DihydroestreptoMycin Sulfate | | CAS: | 128-46-1 | | MF: | C21H41N7O12 | | MW: | 583.59 | | EINECS: | 204-888-2 | | Mol File: | 128-46-1.mol |  |
Use
Dihydrostreptomycin, a derivative of the aminoglycoside
antibiotic streptomycin with similar antibacterial activity, was first synthesized in
1947 and subsequently used in the treatment of tuberculosis and gram-negative
infections. Preparations for systemic use have been widely withdrawn as a result
of concern regarding their severe ototoxicity. Dihydrostreptomycin is poorly
absorbed from the gastrointestinal tract. It remains available in oral preparations in
some countries.
- Dihydrostreptomycin
-
- US $1.00 / g
- 2019-12-26
- CAS:128-46-1
- Min. Order: 1g
- Purity: ≥98%
- Supply Ability: g/kg/Ton
|
|
128-46-1
Recommend Suppliers |
|